Literature DB >> 29502204

AMPKα inactivation destabilizes atherosclerotic plaque in streptozotocin-induced diabetic mice through AP-2α/miRNA-124 axis.

Wen-Jing Liang1, Sheng-Nan Zhou1, Mei-Rong Shan1, Xue-Qin Wang1, Miao Zhang1, Yuan Chen1, Yun Zhang2, Shuang-Xi Wang3, Tao Guo4.   

Abstract

Diabetes mellitus is one of risk factors of cardiovascular diseases including atherosclerosis. Whether and how diabetes promotes the formation of unstable atherosclerotic plaque is not fully understood. Here, we show that streptozotocin-induced type 1 diabetes reduced collagen synthesis, leading to the formation of unstable atherosclerotic plaque induced by collar placement around carotid in apolipoprotein E knockout (Apoe-/-) mice. These detrimental effects of hyperglycemia on plaque stability were reversed by metformin in vivo without altering the levels of blood glucose and lipids. Mechanistically, we found that high glucose reduced the phosphorylated level of AMP-activated protein kinase alpha (AMPKα) and the transcriptional activity of activator protein 2 alpha (AP-2α), increased the expression of miR-124 expression, and downregulated prolyl-4-hydroxylase alpha 1 (P4Hα1) protein expression and collagen biosynthesis in cultured vascular smooth muscle cells. Importantly, these in vitro effects produced by high glucose were abolished by AMPKα pharmacological activation or adenovirus-mediated AMPKα overexpression. Further, adenovirus-mediated AMPKα gain of function remitted the process of diabetes-induced plaque destabilization in Apoe-/- mice injected with streptozotocin. Administration of metformin enhanced pAP-2α level, reduced miR-124 expression, and increased P4Hα1 and collagens in carotid atherosclerotic plaque in diabetic Apoe-/- mice. We conclude that streptozotocin-induced toxic diabetes promotes the formation of unstable atherosclerotic plaques based on the vulnerability index in Apoe-/- mice, which is related to the inactivation of AMPKα/AP-2α/miRNA-124/P4Hα1 axis. Clinically, targeting AMPKα/AP-2α/miRNA-124/P4Hα1 signaling should be considered to increase the plaque stability in patients with atherosclerosis. KEY MESSAGES: Hyperglycemia reduced collagen synthesis, leading to the formation of unstable atherosclerotic plaque induced by collar placement around carotid in apolipoprotein E knockout mice. Hyperglycemia destabilizes atherosclerotic plaque in vivo through an AMPKα/AP-2α/miRNA-124/P4Hα1-dependent collagen synthesis. Metformin functions as a stabilizer of atherosclerotic plaque to reduce acute coronary accent.

Entities:  

Keywords:  AMPKα; AP-2α; Atherosclerosis; Diabetes; P4Hα1; miR-124

Mesh:

Substances:

Year:  2018        PMID: 29502204     DOI: 10.1007/s00109-018-1627-8

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  35 in total

1.  Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation.

Authors:  Yasuo Ido; David Carling; Neil Ruderman
Journal:  Diabetes       Date:  2002-01       Impact factor: 9.461

2.  Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice.

Authors:  Mengwei Zang; Shanqin Xu; Karlene A Maitland-Toolan; Adriana Zuccollo; Xiuyun Hou; Bingbing Jiang; Michel Wierzbicki; Tony J Verbeuren; Richard A Cohen
Journal:  Diabetes       Date:  2006-08       Impact factor: 9.461

Review 3.  Hypothalamic AMPK: a canonical regulator of whole-body energy balance.

Authors:  Miguel López; Rubén Nogueiras; Manuel Tena-Sempere; Carlos Diéguez
Journal:  Nat Rev Endocrinol       Date:  2016-05-20       Impact factor: 43.330

4.  ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.

Authors:  Y Nakashima; A S Plump; E W Raines; J L Breslow; R Ross
Journal:  Arterioscler Thromb       Date:  1994-01

Review 5.  Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations.

Authors:  Cecilia C Low Wang; Connie N Hess; William R Hiatt; Allison B Goldfine
Journal:  Circulation       Date:  2016-06-14       Impact factor: 29.690

6.  Diabetes and mortality following acute coronary syndromes.

Authors:  Sean M Donahoe; Garrick C Stewart; Carolyn H McCabe; Satishkumar Mohanavelu; Sabina A Murphy; Christopher P Cannon; Elliott M Antman
Journal:  JAMA       Date:  2007-08-15       Impact factor: 56.272

7.  Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.

Authors:  Prabhakara R Nagareddy; Andrew J Murphy; Roslynn A Stirzaker; Yunying Hu; Shiquing Yu; Rachel G Miller; Bhama Ramkhelawon; Emilie Distel; Marit Westerterp; Li-Shin Huang; Ann Marie Schmidt; Trevor J Orchard; Edward A Fisher; Alan R Tall; Ira J Goldberg
Journal:  Cell Metab       Date:  2013-05-07       Impact factor: 27.287

Review 8.  Development and consequences of insulin resistance: lessons from animals with hyperinsulinaemia.

Authors:  E Shafrir
Journal:  Diabetes Metab       Date:  1996-04       Impact factor: 6.041

9.  Diabetes adversely affects macrophages during atherosclerotic plaque regression in mice.

Authors:  Saj Parathath; Lisa Grauer; Li-Shin Huang; Marie Sanson; Emilie Distel; Ira J Goldberg; Edward A Fisher
Journal:  Diabetes       Date:  2011-05-11       Impact factor: 9.461

10.  In vivo activation of AMP-activated protein kinase attenuates diabetes-enhanced degradation of GTP cyclohydrolase I.

Authors:  Shuangxi Wang; Jian Xu; Ping Song; Benoit Viollet; Ming-Hui Zou
Journal:  Diabetes       Date:  2009-06-15       Impact factor: 9.461

View more
  14 in total

1.  Excessive expression of miR-1a by statin causes skeletal injury through targeting mitogen-activated protein kinase kinase kinase 1.

Authors:  Chang-Ning Fu; Jia-Wen Song; Zhi-Peng Song; Qian-Wen Wang; Wen-Wu Bai; Tao Guo; Peng Li; Chao Liu; Shuang-Xi Wang; Bo Dong
Journal:  Aging (Albany NY)       Date:  2021-04-16       Impact factor: 5.682

2.  Geniposide Combined With Notoginsenoside R1 Attenuates Inflammation and Apoptosis in Atherosclerosis via the AMPK/mTOR/Nrf2 Signaling Pathway.

Authors:  Xiaoyu Liu; Yuling Xu; Saibo Cheng; Xinghong Zhou; Fenghua Zhou; Peikun He; Fang Hu; Lifang Zhang; Yuyao Chen; Yuhua Jia
Journal:  Front Pharmacol       Date:  2021-07-07       Impact factor: 5.810

3.  A minimally invasive approach to induce myocardial infarction in mice without thoracotomy.

Authors:  Quan Sun; Kang-Kai Wang; Miao Pan; Ji-Peng Zhou; Xue-Ting Qiu; Zhen-Yu Wang; Zhen Yang; Yan Chen; Hong Shen; Qi-Lin Gu; Long-Hou Fang; Guo-Gang Zhang; Yong-Ping Bai
Journal:  J Cell Mol Med       Date:  2018-09-14       Impact factor: 5.310

Review 4.  MicroRNAs as Therapeutic Targets and Clinical Biomarkers in Atherosclerosis.

Authors:  Emma L Solly; Catherine G Dimasi; Christina A Bursill; Peter J Psaltis; Joanne T M Tan
Journal:  J Clin Med       Date:  2019-12-13       Impact factor: 4.241

5.  Overexpression of long noncoding RNA ANRIL inhibits phenotypic switching of vascular smooth muscle cells to prevent atherosclerotic plaque development in vivo.

Authors:  Da-Jun Hu; Zhen-Yu Li; Yuan-Ting Zhu; Chuan-Chang Li
Journal:  Aging (Albany NY)       Date:  2020-12-19       Impact factor: 5.682

6.  Amorphous nano-selenium quantum dots prevent pulmonary arterial hypertension through recoupling endothelial nitric oxide synthase.

Authors:  Mo-Li Zhu; Zhi-Tao Gao; Jun-Xiu Lu; Yang Wang; Ge Wang; Tian-Tian Zhu; Peng Li; Chao Liu; Shuang-Xi Wang; Lin Yang
Journal:  Aging (Albany NY)       Date:  2020-12-15       Impact factor: 5.682

7.  Berberine Ameliorates High Glucose-Induced Cardiomyocyte Injury via AMPK Signaling Activation to Stimulate Mitochondrial Biogenesis and Restore Autophagic Flux.

Authors:  Weijian Hang; Benhong He; Jiehui Chen; Liangtao Xia; Bing Wen; Tao Liang; Xu Wang; Qianying Zhang; Yue Wu; Qingjie Chen; Juan Chen
Journal:  Front Pharmacol       Date:  2018-10-03       Impact factor: 5.810

8.  Endogenous reduction of miR-185 accelerates cardiac function recovery in mice following myocardial infarction via targeting of cathepsin K.

Authors:  Chuan-Chang Li; Xue-Ting Qiu; Quan Sun; Ji-Peng Zhou; Hui-Jun Yang; Wan-Zhou Wu; Ling-Fang He; Can-E Tang; Guo-Gang Zhang; Yong-Ping Bai
Journal:  J Cell Mol Med       Date:  2018-11-18       Impact factor: 5.310

9.  Vitamin B6 inhibits macrophage activation to prevent lipopolysaccharide-induced acute pneumonia in mice.

Authors:  Mei-Rong Shan; Sheng-Nan Zhou; Chang-Ning Fu; Jia-Wen Song; Xue-Qing Wang; Wen-Wu Bai; Peng Li; Ping Song; Mo-Li Zhu; Zhi-Min Ma; Zhan Liu; Jian Xu; Bo Dong; Chao Liu; Tao Guo; Cheng Zhang; Shuang-Xi Wang
Journal:  J Cell Mol Med       Date:  2020-01-22       Impact factor: 5.310

10.  S-Nitrosylation of Akt by organic nitrate delays revascularization and the recovery of cardiac function in mice following myocardial infarction.

Authors:  Xiao-Yan Li; Hong-Ming Zhang; Gui-Peng An; Mo-Yan Liu; Shu-Fang Han; Qun Jin; Ying Song; Yi-Meng Lin; Bo Dong; Shuang-Xi Wang; Ling-Bo Meng
Journal:  J Cell Mol Med       Date:  2020-10-30       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.